Magnesium Sulfate Diluent Selection
For magnesium sulfate intravenous infusions, use either 5% Dextrose Injection or 0.9% Sodium Chloride (Normal Saline) as the diluent, diluting to a concentration of 20% or less prior to administration 1.
FDA-Approved Diluent Options
The FDA drug label explicitly states that solutions for IV infusion must be diluted to a concentration of 20% or less, with two standard diluents 1:
- 5% Dextrose Injection, USP
- 0.9% Sodium Chloride Injection, USP
Both diluents are equally acceptable and the choice between them should be based on the clinical context and patient-specific factors.
Clinical Context for Diluent Selection
When to Use 5% Dextrose:
- Pre-eclampsia/eclampsia management: The WHO guidelines describe magnesium sulfate administration as "4 g IV in 250 mL of 5% Dextrose" for severe pre-eclampsia 2
- Patients without concerns for hyperglycemia
- Standard obstetric protocols
When to Use 0.9% Sodium Chloride:
- Pediatric maintenance fluids: Recent AAP guidelines recommend isotonic solutions (0.9% NaCl) for maintenance IV fluids in children to prevent hyponatremia 3
- Patients with diabetes or hyperglycemia concerns
- When avoiding dextrose-related complications
Concentration Guidelines:
- Standard dilution: 20% or less concentration for IV infusion 1
- Example for eclampsia: 4-5 g in 250 mL yields approximately 1.6-2% solution 1
- Pediatric dosing: 25-50 mg/kg over 10-20 minutes, diluted appropriately 4, 5
Administration Rate Considerations
The rate of IV injection should generally not exceed 150 mg/minute (1.5 mL of a 10% concentration), except in severe eclampsia with seizures 1. For maintenance infusions:
- Eclampsia: 1 g/hour continuous infusion 2
- Torsades de pointes: 25-50 mg/kg over 10-20 minutes 4, 5
- Severe asthma: 25-50 mg/kg over 15-30 minutes 5
Critical Safety Points
- Never administer the undiluted 50% solution intravenously - this concentration is only appropriate for deep IM injection in adults 1
- Monitor for magnesium toxicity: check patellar reflexes and respiratory rate (should be ≥16 breaths/min) 2, 1
- Maintain urine output at ≥100 mL during the 4 hours preceding each dose 1
- Have calcium chloride immediately available to counteract potential magnesium toxicity 1
Common Pitfall to Avoid
The most critical error is administering concentrated magnesium sulfate without proper dilution. The 50% solution (500 mg/mL) must be diluted before IV administration to prevent severe local reactions, cardiovascular complications, and rapid hypermagnesemia 1. Research confirms that properly diluted magnesium sulfate infusions pose no significant cardiovascular, hepatic, renal, or metabolic toxicity concerns 6.